The 20 Best Pulmonary Valves Agenesis Doctors Near Me in District of Columbia, US

Michael Bykhovsky, MD, is an adult congenital heart disease specialist and pediatric cardiologist. He completed his subspecialty training in adult congenital heart disease at Stanford University, with prior pediatric cardiology training at the Children's Hospital of Georgia. He is additionally board certified in internal medicine and pediatrics with residency at Stony Brook University. Publications Google Scholar|ORCiD. Dr. Bykhovsky is rated as an Experienced provider by MediFind in the treatment of Pulmonary Valves Agenesis. His clinical expertise encompasses Tricuspid Atresia, Tetralogy of Fallot, Double Discordia, and Ebstein's Anomaly. Dr. Bykhovsky is board certified in American Board Of Pediatrics, 2020, Internal Medicine: American Board Of Internal Medicine, 2018, Pediatrics: American Board Of Pediatrics, 2017, and Adult Congenital Heart Disease: American Board Of Internal Medicine, 2017.

Uyen Truong, MD, specializes in pediatric cardiac non-invasive imaging, with a focus in cardiac magnetic resonance (CMR) and computed tomography (CT). Her primary research focus over the past decade has been the use of MRIs to derive hemodynamic data that were conventionally obtained from invasive cardiac catheterization measures. She believes that utilization of echocardiograms and MRIs are critical in caring for children and their full capability to understand the state of the disease has yet to be established. Dr. Truong led a team in developing and exploring the utility of 4-dimensional flow MRI in characterizing the vasculature of children at the Children’s Hospital of Colorado. She has received intramural and extramural funding to study the vasculature and deformation in the myocardium of children, including an NIH K23 from NHLBI that focuses on children with pulmonary hypertension. She has also worked in partnership with Pediatric Emergency Medicine, Advanced Vascular Imaging and Psychiatry to study early cardiovascular maladaptive changes associated with adverse childhood events, including trauma and abuse. Adverse childhood events, unfortunately, affects a large proportion of the population. Dr. Truong's team strongly believes that early identification of maladaptive cardiovascular function in response to stress allows for more effective intervention in this cohort of children. They hope through their successful collaboration that they can improve clinical outcomes and affect policies and improve resources allocated for these children. Dr. Truong is rated as an Experienced provider by MediFind in the treatment of Pulmonary Valves Agenesis. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Pulmonary Hypertension, Hypertension, Type 1 Diabetes (T1D), Tetralogy of Fallot, and Osteotomy. Dr. Truong is board certified in American Board Of Pediatrics, 2012.

Ashraf Harahsheh, MD, FACC, FAAP, joined Children’s National Hospital in September 2008 as a full-time attending. He is currently the director of the Kawasaki Disease Program and Cardiology Resident Education and is active in inpatient and outpatient care, as well in the Preventive Cardiology Program with a focus on hyperlipidemia. Dr. Harahsheh completed his fellowship training at the Children’s Hospital of Michigan, Wayne State University School of Medicine, Detroit, Mich. Dr. Harahsheh is board certified in pediatric cardiology. He is a fellow of the American Academy of Pediatrics and the American College of Cardiology and a member of the National Lipid Association and the Academic Pediatric Association. Dr. Harahsheh received his doctorate of medicine from the University of Jordan-College of Medicine, Amman, Jordan. He is an active member of the Joint Council on Congenital Heart Disease’s National Pediatric Cardiology Quality Improvement Collaborative (NPC-QIC). His research interests include resource utilization, quality improvement and development of new educational programs teaching the next generation of providers communication skills surrounding subspecialty referral. Dr. Harahsheh sees patients at the Children’s National main campus, Children's National Annapolis, Children's National Upper Marlboro, Cardiology Clinic at Charlotte Hall, Md., and Virginia Hospital Center in Arlington, Va. Dr. Harahsheh’s recent honors and awards include: 2016-2017 Who’s Who in Science and Engineering (Marquis Who’s Who Publications) Top 10 Cardiologist 2014 (Vitals) 2014 ACC Teaching Skills Workshop for Emerging Faculty Course Guide to America’s Top Pediatricians 2014 Edition (Consumer’s Research Council of America) 2014 Honorable Mention in Education (Children’s National Health System) 2017 Certificate of Excellence at the Seventh Annual Children's National Health System Research and Education Week. Dr. Harahsheh is rated as an Experienced provider by MediFind in the treatment of Pulmonary Valves Agenesis. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Multisystem Inflammatory Syndrome in Children (MIS-C), Kawasaki Disease, Coronary Artery Aneurysm, Pediatric Myocarditis, and Heart Transplant. Dr. Harahsheh is board certified in Pediatric Cardiology: American Board Of Pediatrics, 2008 and Pediatrics: American Board Of Pediatrics, 2004.

Mary T. Donofrio, MD, FAAP, FACC, FASE, is a professor of pediatrics at George Washington University School of Medicine and is a pediatric and fetal cardiologist at Children's National Hospital in Washington D.C. She is the VanMetre Companies endowed chair of fetal cardiology and is medical director of Prenatal Cardiology, director of the Critical Care Delivery Program and Advanced Cardiac Imaging Fellowship, and co-director of the Cardiac Neurodevelopmental Outcome Program. She is the founding president of the Fetal Heart Society, a non-profit international organization created to advance the field of fetal cardiovascular care and science through collaborative research, education and mentorship. Dr. Donofrio is an international expert in fetal cardiology and is known for her work in establishing multidisciplinary protocols for specialized delivery room management of babies diagnosed in utero with complex congenital heart disease. She has collaborated with scientists in the field to study how alterations in the fetal circulation affect in utero brain development as well as to investigate potential treatment strategies to improve neurodevelopmental outcome in babies with congenital heart disease. She has published over 150 papers, including the American Heart Association Scientific Statement on the Diagnosis and Treatment of Fetal Cardiac Disease, the American Society of Echocardiography Guidelines and Recommendations for Performance of the Fetal Echocardiogram, and the Call to Action Report on Prioritizing Delivery Room Care for Neonates with Critical Congenital Heart Disease. Publications: PUBMED. Dr. Donofrio is rated as an Experienced provider by MediFind in the treatment of Pulmonary Valves Agenesis. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Congenital Heart Disease (CHD), Double Aortic Arch, Vascular Ring, Ebstein's Anomaly, and Septoplasty. Dr. Donofrio is board certified in Pediatric Cardiology: American Board Of Pediatrics, 1996.